Market Tracker

11/21 6:05pm ET

Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
8.88 -0.10 / -1.11%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.88 +0.0011 / +0.01%
 
Volume: 341.00

Today’s Trading

Previous close8.98
Today’s open9.09
Day’s range8.85 - 9.10
Volume431,170
Average volume (3 months)392,084
Market cap$385.5M
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)-6.62%
Earnings growth (this year)+103.62%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+712.09%
P/E ratioNM
Price/Sales19.98
Price/Book10.73

Competitors

 Today’s
change
Today’s
% change
RVNCRevance Therapeutics...+0.36+2.24%
DVAXDynavax Technologies...-0.22-1.52%
ZIOPZIOPHARM Oncology In...+0.15+4.04%
DERMDermira Inc+0.16+0.99%
Data as of 4:00pm ET, 11/21/2014

Financials

Last reporting dateNovember 11, 2014
EPS forecast (this quarter)$0.32
Annual revenue (last year)$12.0M
Annual profit (last year)-$92.3M
Net profit margin-767.73%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, Director &
Secretary
Jack A. Khattar
CFO, Vice President &
Head-Investor Relations
Gregory S. Patrick
Corporate headquarters
Rockville, Maryland

Forecasts